| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.17 | 0.3 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.13 | 0.3 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.057 | 0.3 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.06 | 0.3 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.16 | 0.4 |